Sarepta Therapeutics, Inc.
News
SRPT Makes Notable Cross Below Critical Moving Average
Market News Video In trading on Thursday, shares of Sarepta Therapeutics Inc (SRPT) crossed below their 200 day moving average of 125.11, changing hands as low as 124.49 per share. Sarepta Therapeutics Inc...\n more…
12,137 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Acquired by Natixis Advisors LLC
Zolmax Natixis Advisors LLC bought a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The...\n more…
Emerald Advisers LLC Buys 2,426 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Ticker Report Emerald Advisers LLC lifted its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 130.9% during the 2nd quarter, according to its most recent 13F filing with the Securities &...\n more…
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by TD Asset Management Inc
Ticker Report TD Asset Management Inc reduced its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 9.9% during the 2nd quarter, HoldingsChannel reports. The institutional investor...\n more…
CIBC Asset Management Inc Boosts Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Zolmax CIBC Asset Management Inc grew its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 13.7% in the 2nd quarter, according to the company in its most recent filing with the Securities...\n more…
Royal Bank of Canada Reiterates "Outperform" Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Zolmax Sarepta Therapeutics (NASDAQ:SRPT - Get Free Report)s stock had its "outperform" rating restated by stock analysts at Royal Bank of Canada in a report issued on Friday, Benzinga reports. They...\n more…